Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

A 2-year-old boy with a rare type of lupus causing hair loss improved with oral steroids.

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Microneedling is effective for skin rejuvenation and various skin issues, but more research is needed to confirm its safety and effectiveness.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

A 47-year-old man's eyelid swelling didn't improve with basic treatments, so a biopsy was needed.

Some African American women experience central scalp hair loss, often linked to a history of fungal scalp infection.

About 30% of women feel they lose too much hair, often starting before age 40, and most can't find a reason for it.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

Polymeric nanoparticles show promise for treating skin diseases.

Dermatoscopy is useful for identifying different hair and scalp conditions and can reduce the need for biopsies.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

The document concludes that there are no effective clinical treatments for hearing loss due to hair cell damage, but research is ongoing.

Wound healing insights can improve regenerative medicine.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

Both drugs lower DHT levels, with GI198745 being more effective.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.